TY  - JOUR
AU  - Powers, Camille M
AU  - Yang, Andrew K
AU  - Verma, Hannah
AU  - Orloff, Jeremy
AU  - Piontkowski, Austin J
AU  - Gulati, Nicholas
PY  - 2024
DA  - 2024/5/2
TI  - Online Patient Attitudes Toward Cutaneous Immune-Related Adverse Events Attributed to Nivolumab and Pembrolizumab: Sentiment Analysis
JO  - JMIR Dermatol
SP  - e53792
VL  - 7
KW  - immune checkpoint inhibitor
KW  - immunotherapy
KW  - pembrolizumab
KW  - nivolumab
KW  - cutaneous immune-related adverse event
KW  - medical dermatology
KW  - oncology
KW  - sentiment analysis
SN  - 2562-0959
UR  - https://derma.jmir.org/2024/1/e53792
UR  - https://doi.org/10.2196/53792
UR  - http://www.ncbi.nlm.nih.gov/pubmed/38696235
DO  - 10.2196/53792
ID  - info:doi/10.2196/53792
ER  -